The concentration of circulating CEA has also been shown to be a supportive diagnostic marker in both NSCLC and SCLC, and the receptor carcinoembryonic antigen-associated cell adhesion molecule 5 (CEACAM5) is considered a potential target [67]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.